The Use of Decomposition Methods in Real-World Treatment Benefits Evaluation for Patients with Type 2 Diabetes Initiating Different Injectable Therapies: Findings from the INITIATOR Study-Reference-Cited by-同舟云学术

The Use of Decomposition Methods in Real-World Treatment Benefits Evaluation for Patients with Type 2 Diabetes Initiating Different Injectable Therapies: Findings from the INITIATOR Study

Published:2017-12 Issue:10 Volume:20 Page:1252-1259
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Brekke Lee,Buysman Erin,Grabner Michael,Ke Xuehua,Xie Lin,Baser Onur,Wei Wenhui

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference32 articles.

1. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes;Inzucchi;Diabetes Care,2015

2. American Association of Clinical Endocrinologists’ comprehensive diabetes management algorithm 2013 consensus statement—executive summary;Garber;Endocr Pract,2013

3. AACE/ACE comprehensive diabetes management algorithm 2015;Garber;Endocr Pract,2015

4. Building useful evidence: changing the clinical research paradigm to account for comparative effectiveness research;Greenfield;J Comp Eff Res,2012

5. Wage discrimination: reduced form and structural estimates;Blinder;J Hum Resour,1973

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estimating and Explaining the Differences in Health Care Seeking by Symptom Burden Among Persons With Presumptive Tuberculosis: Findings From a Population-Based Tuberculosis Prevalence Survey in a High-Burden Setting in India;Open Forum Infectious Diseases;2024-07-19

2. Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review;Communications Medicine;2023-10-05

3. Precision medicine in type 2 diabetes: A systematic review of treatment effect heterogeneity for GLP1-receptor agonists and SGLT2-inhibitors;2023-04-22

4. Assessing and communicating heterogeneity of treatment effects for patient subpopulations: Panel discussion on considerations in design and analysis;Pharmaceutical Statistics;2020-10-28

5. Impact of insurance type on national variation in cost of endovascular treatment for unruptured cerebral aneurysms;Journal of NeuroInterventional Surgery;2020-10-19